Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension

J Cardiothorac Vasc Anesth. 2004 Dec;18(6):775-6. doi: 10.1053/j.jvca.2004.08.021.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Inhalation
  • Blood Pressure / drug effects
  • Bronchodilator Agents / therapeutic use*
  • Cardiomegaly / complications
  • Cardiomegaly / surgery
  • Child
  • Drug Administration Schedule
  • Electrocardiography / methods
  • Heart Septal Defects, Ventricular / complications
  • Heart Septal Defects, Ventricular / surgery
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Intubation, Intratracheal / methods
  • Male
  • Nitric Oxide / therapeutic use*
  • Piperazines / administration & dosage
  • Piperazines / therapeutic use*
  • Postoperative Care / methods
  • Purines
  • Severity of Illness Index
  • Sildenafil Citrate
  • Sulfones
  • Time Factors
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*

Substances

  • Bronchodilator Agents
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Nitric Oxide
  • Sildenafil Citrate